Research
Start with the right technology and scale with confidence
LEON: Built to Eliminate Nanoparticle Scale-Up Risk
New independent research confirms the economic case for process-robust manufacturing platforms
A new independent research brief from BioEdge Insights LLC puts numbers behind something LEON was built to solve: nanoparticle manufacturing scale-up is a technical translation challenge, not simply a volume increase. Most mixer geometry transfers require process adjustments, and the largest economic impact is often not the additional batch, but lost time to process lock, GMP readiness, regulatory milestones, or clinical progression - resulting in later time to market and reduced project NPV.
LEON's platform is designed to maintain consistent mixing behavior across development and manufacturing scales, with the potential to eliminate that scale-up rework entirely.
Read the full BioEdge Insights brief for the complete economic framework.
Read the Research Brief
Independent Research Brief · July 2026
Ready to Give Yourself the Best Chance to Succeed?
Contact us to begin your seamless transition from R&D to GMP with one core technology.
Talk to Our Team